MENU
BOLD
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Boundless Bio (BOLD) Earnings Date & Reports
Boundless Bio Inc is a clinical-stage oncology company... Show more
Industry: #Biotechnology
A.I. Advisor
published Earnings
BOLD is expected to report earnings to fall 20.75% to -83 cents per share on November 05
Q3'26
Est.
$-0.84
Q2'26
Missed
by $0.25
Q1'26
Beat
by $0.20
Q4'25
Beat
by $0.58
Q3'25
Beat
by $0.47
The last earnings report on August 24 showed earnings per share of -105 cents, missing the estimate of -81 cents. With 102.70K shares outstanding, the current market capitalization sits at 68.24M.
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information
General Information
a developer of gene therapy products for patients with serious rare diseases
Industry Biotechnology
Profile
Details
Industry
Biotechnology
Address
10955 Alexandria Way
Phone
+1 858 766-9912
Employees
28
Web
https://www.boundlessbio.com